Barclays raised the firm’s price target on Kodiak Sciences (KOD) to $4 from $3 and keeps an Underweight rating on the shares. The firm says the company’s Q3 highlighted recent progress and provided update across key pipeline programs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KOD: